Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies.

Norsworthy, Kelly J; Cho, Eunpi; Arora, Jyoti; Kowalski, Jeanne; Tsai, Hua-Ling; Warlick, Erica; Showel, Margaret; Pratz, Keith W; Sutherland, Lesley A; Gore, Steven D; Ferguson, Anna; Sakoian, Sarah; Greer, Jackie; Espinoza-Delgado, Igor; Jones, Richard J; Matsui, William H; Smith, B Douglas.
Leuk Res; 49: 90-7, 2016 10.
Artigo em Inglês | MEDLINE | ID: mdl-27619199